BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 10757337)

  • 21. Endocervical carcinoma.
    Yeh IT; LiVolsi VA; Noumoff JS
    Pathol Res Pract; 1991 Mar; 187(2-3):129-44. PubMed ID: 2067992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. II. Microinvasive adenocarcinoma.
    Ayer B; Pacey F; Greenberg M
    Acta Cytol; 1988; 32(3):318-24. PubMed ID: 3376698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytology of reversible and irreversible epithelial changes in the uterine cervix].
    Höffken H
    Fortschr Med; 1977 Oct; 95(39):2382-6. PubMed ID: 914197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign and malignant pathology of the cervix, including screening.
    Liao SY; Manetta A
    Curr Opin Obstet Gynecol; 1993 Aug; 5(4):497-503. PubMed ID: 8400047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Accompanying histological changes in the cervix uteri in carcinoma in situ and early invasive carcinoma].
    Krizanac S; Jukić S; Bolanca M
    Lijec Vjesn; 1987; 109(11-12):418-21. PubMed ID: 3695790
    [No Abstract]   [Full Text] [Related]  

  • 28. [Histometric study of 55 cases of carcinoma in situ and microinvasive carcinoma of the cervix. Histogenetic deductions].
    Brémond A; Dargent D; Lesbros F
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(7):879-94. PubMed ID: 1002956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
    Höffken H; Rummel HH
    Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix.
    Maier RC; Norris HJ
    Obstet Gynecol; 1980 Sep; 56(3):361-4. PubMed ID: 7422175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma of the uterine cervix: a review of its pathology and commentary on the problem in Malaysians.
    Cheah PL; Looi LM
    Malays J Pathol; 1999 Jun; 21(1):1-15. PubMed ID: 10879274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytopathology and the management of early invasive cancer of the uterine cervix.
    Johnston WW; Myers B; Creasman WT; Owens SM
    Obstet Gynecol; 1982 Sep; 60(3):350-3. PubMed ID: 7121916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glandular lesions of the uterine cervix: the present state of our knowledge.
    Wells M; Brown LJ
    Histopathology; 1986 Aug; 10(8):777-92. PubMed ID: 3758950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
    Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist?
    Goldstein NS; Ahmad E; Hussain M; Hankin RC; Perez-Reyes N
    Am J Clin Pathol; 1998 Aug; 110(2):200-9. PubMed ID: 9704619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphology and histogenesis problems in cervical cancer].
    Iakovleva IA; Chernyĭ AP
    Arkh Patol; 1985; 47(3):19-27. PubMed ID: 2988485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ.
    Baker PM; Clement PB; Bell DA; Young RH
    Int J Gynecol Pathol; 1999 Jul; 18(3):198-205. PubMed ID: 12090586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Local connective tissue reaction in cervical cancer].
    Shendereva TS
    Vopr Onkol; 1979; 25(3):9-14. PubMed ID: 433210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomenclature of precancerous lesions of the uterine cervix. A position paper.
    Drake M
    Acta Cytol; 1984; 28(5):527-34. PubMed ID: 6592915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laminin-5 gamma2 chain immunohistochemistry facilitates the assessment of invasiveness and improves the diagnostic reproducibility of glandular lesions of the cervix uteri.
    Negri G; Romano F; Vittadello F; Kasal A; Mazzoleni G; Colombetti V; Egarter-Vigl E
    Hum Pathol; 2006 Jun; 37(6):704-10. PubMed ID: 16733211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.